Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
5 High Dividend-Yielding S&P 500 Stocks Amid Coronavirus Woes
by Swayta Shah
At a time when the coronavirus outbreak has hampered steady stream of income for many, investing in high dividend-yielding stocks can be rewarding. We have picked 5 S&P 500 stocks worth considering.
Clorox (CLX) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Clorox (CLX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
New Strong Buy Stocks For July 2nd
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Clorox (CLX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Clorox (CLX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $219.37 in the latest trading session, marking a +0.82% move from the prior day.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
5 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Consumer Staples a Safe Bet Amid Economic Woes: 5 Picks
by Ansuiya Mohta
Mounting fears related to higher coronavirus infections have raised vulnerability, making the defensive consumer staple space a safe investment option.
McCormick (MKC) Q2 Earnings Beat Estimates, Sales up
by Zacks Equity Research
McCormick's (MKC) second-quarter 2020 results reflect the impact of higher sales, thanks to coronavirus-led higher at-home consumption.
Procter & Gamble Displays Strength on Demand for Products
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from increased demand for hand soaps, detergents and surface-cleaning products during the pandemic.
Buy 5 Top Consumer Staple Stocks to Minimize Portfolio Risks
by Nalak Das
It will be prudent to invest in consumer staple stocks with a favorable Zacks Rank to minimize portfolio risks.
Clorox (CLX) Stock Moves -0.63%: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $212.03, moving -0.63% from the previous trading session.
Rising COVID-19 Cases PlagueTyson Foods' Exports to China
by Zacks Equity Research
China government halts chicken exports from Tyson Foods' (TSN) Springdale facility as the COVID-19 has reportedly hit the plant.
Kimberly-Clark (KMB) Looks Scrumptious on Cost-Saving Efforts
by Zacks Equity Research
Kimberly-Clark (KMB) is witnessing higher consumer demand owing to coronavirus induced stockpiling. Also, robust cost-saving efforts bode well.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $214.59, marking a +1.22% move from the previous day.
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
5 Consumer Staple Dividend Stocks to Enrich Your Portfolio
by Vrishali Bagree
At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.
Buy Clorox (CLX) Stock Now for Coronavirus Volatility and Beyond?
by Benjamin Rains
Clorox shares have surged 35% in 2020 to crush the S&P 500's 5% decline as its disinfectant wipes fly off the shelves during the coronavirus pandemic. With this in mind, investors might want to consider buying CLX stock as coronavirus volatility returns...
3 Reasons Why Growth Investors Shouldn't Overlook Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) could produce exceptional returns because of its solid growth attributes.
Clorox (CLX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $205.12, moving +0.09% from the previous trading session.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
5 Defensive Stocks to Buy as Coronavirus Cases Rise Again
by Zacks Equity Research
An alarming rise in the number of coronavirus cases results in volatility in the market and raises the appeal of defensive stocks
Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge
by Zacks Equity Research
Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge